Vapreotide

Synthetic somatostatin analog

Chemical structure of Vapreotide

Vapreotide is a synthetic somatostatin analog used primarily in the treatment of certain types of cancer and gastrointestinal disorders. It mimics the action of natural somatostatin, a hormone that inhibits the release of several other hormones and secretions in the body.

Pharmacology

Vapreotide is a cyclic peptide that acts as an agonist at somatostatin receptors. It has a high affinity for the somatostatin receptor subtypes 2, 3, and 5. By binding to these receptors, vapreotide inhibits the secretion of growth hormone, insulin, and glucagon.

Medical uses

Vapreotide is used in the management of acromegaly, a condition characterized by excessive production of growth hormone. It is also employed in the treatment of gastrointestinal bleeding associated with esophageal varices in patients with cirrhosis.

Mechanism of action

The drug works by mimicking the action of somatostatin, thereby reducing the secretion of various hormones and neurotransmitters. This action helps in controlling symptoms associated with hormone-secreting tumors and other related conditions.

Side effects

Common side effects of vapreotide include nausea, vomiting, diarrhea, and abdominal pain. Long-term use may lead to gallstone formation due to reduced gallbladder motility.

History

Vapreotide was developed as part of efforts to create longer-acting and more potent analogs of somatostatin. It has been studied extensively for its potential benefits in treating various endocrine and gastrointestinal disorders.

Research

Ongoing research is exploring the use of vapreotide in other conditions, such as neuroendocrine tumors and pancreatic cancer. Studies are also investigating its efficacy in combination with other therapeutic agents.

Related pages

• Somatostatin
• Somatostatin receptor
• Acromegaly
• Esophageal varices